Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute effects of ketamine on NMDA receptor measured by PET with (R)-[11C]-Me-NB1
2022-003266-21Phase 4Terminated
- Sponsor
- Medical University of Vienna
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine in None (2 arms), sponsored by Medical University of Vienna. Started Dec 2022; status: terminated.
02
Drugs
ketamine
Beyond the preview
Go deeper on 2022-003266-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003266-21.